[go: up one dir, main page]

BR9916515A - Polinucleotìdeo, vetor de expressão, células de e. coli e de agrobacterium tumefaciens transformadas com o vetor de expressão, célula de planta transgênica, semente de planta transgênica, célula eucariótica transgênica, composição imunogênica, método de evocar uma resposta imune em um animal ou ser humano, planta transgênica, e, adjuvante - Google Patents

Polinucleotìdeo, vetor de expressão, células de e. coli e de agrobacterium tumefaciens transformadas com o vetor de expressão, célula de planta transgênica, semente de planta transgênica, célula eucariótica transgênica, composição imunogênica, método de evocar uma resposta imune em um animal ou ser humano, planta transgênica, e, adjuvante

Info

Publication number
BR9916515A
BR9916515A BR9916515-5A BR9916515A BR9916515A BR 9916515 A BR9916515 A BR 9916515A BR 9916515 A BR9916515 A BR 9916515A BR 9916515 A BR9916515 A BR 9916515A
Authority
BR
Brazil
Prior art keywords
transgenic plant
expression vector
transgenic
coli
adjuvant
Prior art date
Application number
BR9916515-5A
Other languages
English (en)
Inventor
Hugh S Mason
Charles J Arntzen
Original Assignee
Thompson Boyce Plant Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thompson Boyce Plant Res filed Critical Thompson Boyce Plant Res
Publication of BR9916515A publication Critical patent/BR9916515A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"POLINUCLEOTìDEO,VETOR DE EXPRESSãO, CéLULAS DE COLI E DE AGROBACTERIUM TUMEFACIENS TRANSFORMADAS COM O VETOR DE EXPRESSãO, CéLULA DE PLANTA TRANSGêNICA, SEMENTE DE PLANTA TRANSGêNICA CéLULA EUCARIóTICA TRANSGêNICA, COMPOSIçãO IMUNOGêNICA, MéTODO DE EVOCAR UMA RESPOSTA IMUNE EM UM ANIMAL OU SER HUMANO, PLANTA TRANSGêNICA, E, ADJUVANTE". A invenção fornece polipeptídeos mutantes de Escherichia coli instáveis ao calor (LT) e da toxina Vibrio cholerae (CT) e os polinucleotídeos que os codificam. Os polipeptídeos mutantes LT e CT podem ser facilmente produzidos em plantas e podem ser usados para tratar ou impedir doenças causadas pelo E. coli e pelo V. cholera. Os polipeptídeos também são utilizáveis como adjuvantes.
BR9916515-5A 1998-12-22 1999-12-22 Polinucleotìdeo, vetor de expressão, células de e. coli e de agrobacterium tumefaciens transformadas com o vetor de expressão, célula de planta transgênica, semente de planta transgênica, célula eucariótica transgênica, composição imunogênica, método de evocar uma resposta imune em um animal ou ser humano, planta transgênica, e, adjuvante BR9916515A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11350798P 1998-12-22 1998-12-22
PCT/US1999/030747 WO2000037609A2 (en) 1998-12-22 1999-12-22 Orally immunogenic bacterial enterotoxins expressed in transgenic plants

Publications (1)

Publication Number Publication Date
BR9916515A true BR9916515A (pt) 2001-11-06

Family

ID=22349850

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916515-5A BR9916515A (pt) 1998-12-22 1999-12-22 Polinucleotìdeo, vetor de expressão, células de e. coli e de agrobacterium tumefaciens transformadas com o vetor de expressão, célula de planta transgênica, semente de planta transgênica, célula eucariótica transgênica, composição imunogênica, método de evocar uma resposta imune em um animal ou ser humano, planta transgênica, e, adjuvante

Country Status (9)

Country Link
US (1) US20030176653A1 (pt)
EP (1) EP1175144A4 (pt)
JP (1) JP2002533068A (pt)
CN (1) CN1191357C (pt)
AU (1) AU773953B2 (pt)
BR (1) BR9916515A (pt)
CA (1) CA2359586A1 (pt)
MX (1) MXPA01006294A (pt)
WO (1) WO2000037609A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513371D0 (en) * 1995-06-30 1995-09-06 Biocine Spa Immunogenic detoxified mutant toxins
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
AU776855B2 (en) * 1998-12-23 2004-09-23 Boyce Thompson Institute For Plant Research Inc. Expression of immunogenic hepatitis B surface antigens in transgenic plants
EP1404368B1 (en) * 2001-06-07 2009-12-09 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
CA2449670A1 (en) * 2001-06-07 2002-12-12 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
EP1404851A4 (en) * 2001-06-08 2005-05-25 Icon Genetics Inc PRODUCTION OF PLANT PROTEINS
AU2003210814A1 (en) * 2002-02-12 2003-09-04 Cornell Research Foundation, Inc. PSEUDOMONAS SYRINGAE HARPINS, HopPtoP AND HopPmaHPTO, AND THEIR USES
CA2491568A1 (en) * 2002-08-27 2004-03-11 Dow Agrosciences Llc Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry
WO2005116216A1 (ja) 2004-05-31 2005-12-08 The Kitasato Institute 遺伝子組換え植物による抗原虫病経口ワクチン
US20090304733A1 (en) * 2004-07-28 2009-12-10 Jacob Pitcovski Vaccine comprising recombinant ct or lt toxin
CN100387719C (zh) * 2005-05-09 2008-05-14 中国农业科学院生物技术研究所 编码大肠杆菌热敏毒素基因及其表达载体和用途
CN1324138C (zh) * 2005-07-21 2007-07-04 华东理工大学 大肠杆菌热敏毒素b亚单位的真核表达方法
CA2628308A1 (en) 2005-11-04 2007-05-18 Dow Agrosciences Llc Preparation of vaccine master cell lines using recombinant plant suspension cultures
CN100500842C (zh) * 2006-03-09 2009-06-17 昆明理工大学 一种大肠杆菌热不稳定肠毒素的制备方法
US20080028487A1 (en) * 2006-06-06 2008-01-31 The University Of Nebraska-Lincoln USES OF THE PSEUDOMONAS SYRINGAE EFFECTOR PROTEIN HopU1 RELATED TO ITS ABILITY TO ADP-RIBOSYLATE EUKARYOTIC RNA BINDING PROTEINS
DK2728004T3 (en) 2008-05-02 2018-11-05 Idemitsu Kosan Co Bacterial toxin vaccine
KR101233018B1 (ko) 2010-02-05 2013-02-13 전북대학교산학협력단 대장균 장독소 ｂ 서브유닛 유전자로 형질전환된 식물배양체, 및 이를 포함하는 백신
TW201406389A (zh) * 2010-05-03 2014-02-16 Dev Center Biotechnology 多醣體與大腸桿菌熱不穩定腸毒素之共軛物，其用途及製法
JP6014666B2 (ja) 2012-06-20 2016-10-25 国立大学法人 東京大学 粘膜免疫賦活化剤及びｈｐｖ感染症治療用経口医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101715A (en) * 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
GB9513371D0 (en) * 1995-06-30 1995-09-06 Biocine Spa Immunogenic detoxified mutant toxins
IT1253009B (it) * 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
ES2235176T3 (es) * 1994-10-24 2005-07-01 THE TEXAS A & M UNIVERSITY SYSTEM Inmunizacion oral con plantas transgenicas.
GB9622660D0 (en) * 1996-10-31 1997-01-08 Biocine Spa Immunogenic detoxified mutant toxin
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US6818222B1 (en) * 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
FI110323B (fi) * 1997-06-02 2002-12-31 Timo Korpela Rekombinanttikonstrukti geenin ilmentämisen lisäämiseksi kasveissa

Also Published As

Publication number Publication date
AU2381800A (en) 2000-07-12
CN1331558A (zh) 2002-01-16
CN1191357C (zh) 2005-03-02
MXPA01006294A (es) 2002-06-04
EP1175144A4 (en) 2002-10-30
WO2000037609A2 (en) 2000-06-29
EP1175144A2 (en) 2002-01-30
CA2359586A1 (en) 2000-06-29
AU773953B2 (en) 2004-06-10
JP2002533068A (ja) 2002-10-08
WO2000037609A3 (en) 2000-09-14
US20030176653A1 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
BR9916515A (pt) Polinucleotìdeo, vetor de expressão, células de e. coli e de agrobacterium tumefaciens transformadas com o vetor de expressão, célula de planta transgênica, semente de planta transgênica, célula eucariótica transgênica, composição imunogênica, método de evocar uma resposta imune em um animal ou ser humano, planta transgênica, e, adjuvante
BR9916522A (pt) Vetor de expressão de plantas, célula, semente vegetal, polinucleotìdeo, composição imunogênica, métodos para eliciar uma rsposta imune em mamìfero e para isolar polipeptìdeo, e, planta ou célula vegetal transgênicas
Sourjik et al. Phosphotransfer between CheA, CheY1, and CheY2 in the chemotaxis signal transduction chain of Rhizobium meliloti
Batschauer A plant gene for photolyase: an enzyme catalyzing the repair of UV‐light‐induced DNA damage
BR0208203A (pt) Polipeptìdeo do fator vii, derivado do fator vii, composição, composição farmacêutica, construção de polinucleotìdeo, célula hospedeira eucariótica, animal transgênico, planta transgênica, e, métodos para produzir o polipeptìdeo do fator vii e um derivado do fator vii, uso de um derivado do fator vii, métodos para o tratamento de episódios de hemorragia ou distúrbios de hemorragia em um paciente ou para a intensificação do sistema hemostático normal e para inibir a formação de trobo em um paciente
Alderton et al. Heat adaptation and ion exchange in Bacillus megaterium spores
ES2038122T3 (es) Un procedimiento para la preparacion de una composicion veterinaria2.
GR3024836T3 (en) Fatty acid based compositions for the control of established plant infections
DK0620850T3 (da) Immunogene detoksificerede mutanter af choleratoksin og af toksinet LT, deres fremstilling og deres anvendelse til fremstil
BR0009471A (pt) Composições e processos para modificação de transcrição de gene
DK0539448T3 (da) Levnedsmiddelsammensætninger og farmaceutiske sammensætninger indeholdende kortkædede, monoumættede fedtsyrer og fremgangsmåde til anvendelse
DK1029023T3 (da) Brandhæmmende og biocidt præparat og fremgangsmåde til fremstilling deraf
DE69636735D1 (de) Immunogene, ungiftige choleratoxinmutante
BR9808430A (pt) Método para melhorar a especificidade da regulação de gens em um organismo transformado
Chang et al. Type II heat-labile enterotoxin of Escherichia coli activates adenylate cyclase in human fibroblasts by ADP ribosylation
Robbins et al. Vitamin B6, a growth substance for excised tomato roots
AR035694A1 (es) Procedimiento para preparar vitamina e, contruccion de acido nucleico, combinacion de construcciones de acido nucleico, procedimiento para preparar organismos geneticamente modificados, uso de estos ultimos y uso de acidos nucleicos, construcciones de estos y combinaciones de construcciones en dicho
PT100203A (pt) Sequencia de adn que codifica uma oxalato-oxidase, gene quimerico que incorpora uma tal sequencia, celula vegetal que contem um vector para a transformacao de plantas que compreende um tal gene quimerico e planta transformada proveniente da referida celula
AR036178A1 (es) Genes de la desaturasa del acido graso de la granada y procedimiento para la preparacion de acidos grasos insaturados
Karpova et al. Lectins of Sambucus nigra as biologically active and DNA-protective substances
MX9206806A (es) Pudines listos para tomar que contienen polifosfato
WO1998021222A3 (en) 1-galactose derivatives
AR002648A1 (es) Procedimiento para preparar un producto de carne en trozos.
Fourcroy et al. Phytochrome control of gene expression in radish seedlings II. Far-red light mediated appearance of the ribulose 1, 5-bisphosphate carboxylase and the mRNA for its small subunit
ES2009599A6 (es) Un metodo para producir la toxina p-2 de bacillus thuringiensis.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 13 E 37 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.